Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cannabinoid Receptor
    (1)
  • GNRH Receptor
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

lh21

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
LH 21
T21811611207-11-5
LH-21 is a potent in vivo neutral cannabinoid CB1 receptor antagonist that reduces food intake and body weight gain in obese Zucker rats, resulting in a dose-dependent inhibition of feeding [1].
  • $217
35 days
Size
QTY
Linzagolix
T27837935283-04-8
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.
  • $35
In Stock
Size
QTY